Evidence map›Paper›PMID 24483944›Full record

ArticleBiochemistry2014

Amino acid signature enables proteins to recognize modified tRNA.

Jessica L Spears, Xingqing Xiao, Carol K Hall, Paul F Agris

Open access · hybridAbstract read
In one paragraph

Article in Biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  2. Article
  3. Article
  4. Design of 8-mer Peptides that BlockbioRxiv : the preprint server for biology · 2023
    Article
  5. Article
  6. ACS chemical biology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Exploiting tRNAs to Boost Virulence.Life (Basel, Switzerland) · 2016
    Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jessica L SpearsThe RNA Institute, University at Albany-SUNY , Life Sciences Research Building, Albany, New York 12222, United States.
Xingqing Xiao
Carol K Hall
Paul F Agris
North Carolina State University · US

Funding

TRANSFER RNA STRUCTURE DURING PROTEIN SYNTHESISR01GM023037 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI AGRIS, PAUL F · 1985 to 2010
$1.3M
NIGMS NIH HHS 2R01-GM23037-25
6 · The paper itself

Abstract

Human tRNA(Lys3)UUU is the primer for HIV replication. The HIV-1 nucleocapsid protein, NCp7, facilitates htRNA(Lys3)UUU recruitment from the host cell by binding to and remodeling the tRNA structure. Human tRNA(Lys3)UUU is post-transcriptionally modified, but until recently, the importance of those modifications in tRNA recognition by NCp7 was unknown. Modifications such as the 5-methoxycarbonylmethyl-2-thiouridine at anticodon wobble position-34 and 2-methylthio-N(6)-threonylcarbamoyladenosine, adjacent to the anticodon at position-37, are important to the recognition of htRNA(Lys3)UUU by NCp7. Several short peptides selected from phage display libraries were found to also preferentially recognize these modifications. Evolutionary algorithms (Monte Carlo and self-consistent mean field) and assisted model building with energy refinement were used to optimize the peptide sequence in silico, while fluorescence assays were developed and conducted to verify the in silico results and elucidate a 15-amino acid signature sequence (R-W-Q/N-H-X2-F-Pho-X-G/A-W-R-X2-G, where X can be most amino acids, and Pho is hydrophobic) that recognized the tRNA's fully modified anticodon stem and loop domain, hASL(Lys3)UUU. Peptides of this sequence specifically recognized and bound modified htRNA(Lys3)UUU with an affinity 10-fold higher than that of the starting sequence. Thus, this approach provides an effective means of predicting sequences of RNA binding peptides that have better binding properties. Such peptides can be used in cell and molecular biology as well as biochemistry to explore RNA binding proteins and to inhibit those protein functions.

Indexed as

AlgorithmsAmino AcidsAmino Acid Sequencegag Gene Products, Human Immunodeficiency VirusHumansModels, MolecularMonte Carlo MethodRNA, Transfer, LysSubstrate SpecificityAmino Acidsgag Gene Products, Human Immunodeficiency VirusNCP7 protein, Human immunodeficiency virus 1RNA, Transfer, Lys

Identifiers

PMID24483944
PMCPMC3985708
OpenAlexW1985231519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.